Evaxion Biotech A/S
(EVAX)
undefined
undefined%
At close: undefined
0.91
-1.09%
Pre-market Jan 06, 2025, 07:23 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -0.85 | -1.81 | -3.51 | -10.67 | -14.31 | -34.3 | n/a |
| PS Ratio | 256.88 | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -3.97 | -0.58 | -1.71 | 22.76 | 17.11 | -203.95 | n/a |
| P/FCF Ratio | -1.05 | -1.61 | -3.7 | -12.49 | -22.61 | -95.03 | n/a |
| P/OCF Ratio | -1.06 | -1.63 | -3.93 | -12.88 | -22.8 | -95.37 | n/a |
| OCF/S Ratio | -242.34 | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -1.83 | -0.03 | -0.02 | 0.00 | n/a | -9.2 | n/a |
| Quick Ratio | 1.18 | 4.38 | 8.47 | 2.59 | 6.36 | 1.03 | 9.04 |
| Current Ratio | 1.18 | 3.71 | 8.03 | 1.18 | 6.36 | 0.89 | 9.04 |
| Asset Turnover | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -24.75 | -16.75 | -28.23 | -74.3 | -8.89 | -8.06 | n/a |
| Return on Equity (ROE) | 4.68 | 0.32 | 0.49 | -2.13 | -1.2 | 5.95 | n/a |
| Return on Assets (ROA) | -1.72 | 0.39 | -0.61 | -1.26 | -1.01 | -0.65 | n/a |
| Return on Capital (ROIC) | -3.82 | 0.40 | -0.72 | -2.35 | -1.16 | 6.20 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 99.85% | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -30.31K% | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -31.39K% | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -30.41K% | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -24.35K% | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -29.32K% | n/a | n/a | n/a | n/a | n/a | n/a |